Evidence map›Paper›PMID 41834471›Full record

SynthesisThe Journal of antimicrobial chemotherapy2026

Healthcare providers' experiences in caring for MDRO carriers with a focus on the moral dimensions of care: a systematic review.

Carlijn Damsté, Hester Stoorvogel, Anke Oerlemans, Marjan Knippenberg, Jelle van Gurp, Jaap Ten Oever, Marlies Hulscher

Abstract readSystematic Review
In one paragraph

Synthesis in The Journal of antimicrobial chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carlijn DamstéIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Hester StoorvogelIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Anke OerlemansIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Marjan KnippenbergIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Jelle van GurpIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.
Jaap Ten OeverRadboud Community for Infectious Diseases (RCI), Radboud University Medical Centre, Nijmegen, The Netherlands.ORCID 0000-0003-2397-0125
Marlies HulscherIQ Health Science Department, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-2160-4810

Funding

Gelders Care Network for Antimicrobial resistance and infection prevention
6 · The paper itself

Abstract

objectivesProviding care to multi-drug resistant organisms (MDRO) carriers has a profound impact on healthcare providers (HCPs), potentially challenging their personal and professional values. Understanding HCPs' experiences is key to addressing challenges in providing care to carriers and to support HCPs when providing this care. This review aims to examine experiences of HCPs with a focus on moral dimensions of care.

methodsWe systematically searched Cochrane library, CINAHL, EMBASE, PsycINFO, PubMed and Web of Science. Experiences were analysed using a thematic analysis approach. This review was registered in PROSPERO (CRD42023418340).

resultsEighteen studies were included, primarily conducted in hospitals and nursing homes. Experiences were categorized into three levels: the individual HCP, the care practice and the institutional setting. First, HCPs are uncertain about personal health and safety, have different knowledge levels and question proportionality of infection prevention and control (IPC) measures. Second, HCPs say that wearing PPE limits connection with carriers and note various other challenges regarding the care relationship such as considering how often to enter an isolation room. Third, HCPs face shortages in resources such as time, experience poor infrastructure making it difficult to adhere to IPC measures and specify a need for management support regarding caring for carriers. Moral dimensions of care received limited attention. An example is that HCPs do not want to betray colleagues who ignore IPC measures, but simultaneously fear transmission due to poor compliance.

conclusionsThe diverse experiences provide input for future interventions to support HCPs in caring for MDRO carriers. The limited attention to moral dimensions of care restricts understanding of HCPs' values and challenges. Strengthening support requires further research, particularly qualitative studies led by ethics experts.

Indexed as

Attitude of Health PersonnelCarrier StateDrug Resistance, Multiple, BacterialHealth PersonnelMoralsHumansInfection Control

Identifiers

PMID41834471
PMCPMC13017096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.